New Delhi: Makers of anti-inflammatory drug nimesulide will be required to display cautionary warning labels

Novo Nordisk plans to examine in clinical trials whether its future weight-loss drugs can treat

New Delhi: Novo Holdings, a 142 billion euro investment firm that controls drug maker Novo

India’s diabetes burden is well known, but what’s less visible is the cardiac or heart

Every year, as flu season nears, doctors in India urge people to take the quadrivalent

Living with diabetes isn’t easy. Some days can feel like a constant balancing act. But

The government has directed all pharma companies to revise the MRP of medicines, formulations and

Roche Pharma on Saturday said it has partnered with ten government hospitals to strengthen clinical

Healthcare chain Apollo Hospitals Entreprise Ltd on Friday said it will acquire 31 per cent

At a time when India continues to grapple with challenges in maternal and child health

The new rule by India’s drug regulatory authority, which restricts export of pharmaceutical products labelled

Dr Reddy’s Laboratories on Thursday announced the completion of a definitive transaction with Johnson &

Mumbai: The Delhi High Court on Tuesday restrained the Central Drugs Standard Control Organisation (CDSCO)

New Delhi: The GST rate cuts announced last week will make medicines used for the

New Delhi: India’s drug regulatory authority is considering having braille cards and voice-assisted QR codes

The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal

Mankind Pharma on Monday said it has received approval from the Central Drugs Standard Control

Zydus Lifesciences on Thursday said its subsidiary has joined hands with the Netherlands-based Synthon BV

Health experts have raised serious concerns over the government’s decision to reduce the Goods and

Type 2 diabetes plays a critical role in this growing crisis. In India, where over

Global pharma major AstraZeneca on Saturday announced investment of Rs 176 crore in India to

Aurobindo Pharma on Friday said the US health regulator has issued a Form 483 with

Glenmark Pharmaceuticals on Friday said it has initiated a multi-country Phase 3 clinical trial for

Experts in the pharma industry and med-tech sectors hailed the GST reforms, noting that these

India’s drug regulator plans to ease processes, set fixed approval timelines and explore artificial intelligence

New Delhi: The Centre is set to amend the New Drugs and Clinical Trials Rules,

Welcure Drugs & Pharmaceuticals Ltd on Wednesday said that Singapore-based Telexcell Trade has offered to

New Delhi: Manufactures of medical devices are permitted to provide free evaluation samples to the

India plans to increase pharmaceutical exports to Russia, the Netherlands and Brazil, according to two

Fortis Healthcare Limited today said that its wholly owned subsidiary, International Hospital Limited (IHL), has

If you picture diabetes as an iceberg, the part visible above water represents those living

New Delhi: The pharmaceutical industry may get relief on the long-standing issue of Goods and

A seven-year study, covering a total of 54 private and public hospitals and 200 ICUs

Welcure Drugs & Pharmaceuticals on Monday said its board has approved proposals for a bonus

An international team of scientists has now discovered that people gain more weight on an

Zydus Therapeutics, the US-based innovation-focused specialty arm of Zydus Lifesciences, has announced promising results from

Pharmaceutical firm Murae Organisor said it is evaluating a structured plan to strengthen its agro-sector

Dr Reddy’s Laboratories on Tuesday expressed hope that the new GST structure will take care

Multinational healthcare provider IHH Healthcare on Thursday said it plans to add around 2,000 new

U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans –

Imagine if we could detect heart disease in its earliest, quietest moments in Type 2

New Delhi: The pharmaceutical and medtech industries are worried about the impending Goods and Services

Dr Reddy’s Laboratories on Tuesday said it has launched a first-in-class generic medication for chronic

GlaxoSmithKline Pharmaceuticals is re-entering India’s oncology market with the launch of Jemperli (dostarlimab) and Zejula

Pharmaceuticals Export Promotion Council of India (Pharmexcil) has sought alignment of GST rates on both

A Parliamentary panel has flagged that a substantial segment of cancer drugs are still beyond

Novo Nordisk today said that urge people to buy Novo Nordisk medications only from authorised

Mumbai: India’s healthcare providers are vying for a greater share of overseas patients amid a

India’s private hospital industry has undergone a major ownership shift over the last five years,

The Indian Medical Association (IMA) has sounded a warning bell on the potential misuse and

A parliamentary committee has recommended taking proactive steps to expand the institutional footprint of AYUSH-based

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued an alert to healthcare

Welcure Drugs & Pharmaceuticals Ltd on Wednesday said it will set up an agro-pharma research

MUMBAI: Hyderabad-based Natco Pharma has sued Danish drugmaker Novo Nordisk, maker of blockbuster weight-loss drug

Four new drugs for rare diseases are in the pipeline expected to be launched soon

Mumbai: Aurobindo Pharma has emerged as the frontrunner to acquire Prague-based generic drugmaker Zentiva for

Drug makers Glenmark, Alembic Pharmaceuticals and Sun Pharma are recalling products in the US due

Mumbai: A US government probe into pharmaceutical imports and their implications on national security must

Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to

Rakesh Goyal, a businessman in East Delhi, can’t bear to look at chhole-bhature any longer.

New Delhi: Aurobindo Pharma expects its China facility to break even in the third quarter

Drug firm Pfizer on Monday said it has launched its next-generation 20-valent pneumococcal conjugate vaccine

Asia Healthcare Holdings, a leading healthcare investment platform backed by Singapore’s GIC and TPG, will

The All India Organisation of Chemists and Druggists (AIOCD) has written to Union Home Minister

Intas Pharma has completed the acquisition of UDENYCA for $558 million, the company said in

Managing type 2 diabetes is not just a clinical task; it’s a deeply personal journey.

Cohance Lifesciences on Tuesday announced a strategic investment of USD 10 million (around Rs 87.6

Max Healthcare Institute, India’s largest healthcare chain by market cap, plans to nearly double its

US pharmaceutical major Eli Lilly on Wednesday launched its blockbuster diabetes drug Mounjaro in KwikPen,

New Delhi: The technical committee constituted for supervising clinical trials on new chemical entities has

Drug firm Lupin on Tuesday said it has partnered with Switzerland-based Sandoz Group AG to

Confusion over the ministry of steel’s latest mandate could fuel shortages of surgical blades, needles,

Sales of Danish drugmaker Novo Nordisk’s Wegovy and U.S. rival Eli Lilly’s Mounjaro in India

Indian drug makers are weighing the possible fallout of additional reciprocal tariffs imposed by the

If you have type 2 diabetes (T2D), you might have heard about how it can

Eris Lifesciences, a leading branded formulations manufacturing company, reported a 41% year-on-year increase in net

If you’re living with type 2 diabetes (T2D), obesity, or both, you’re not alone. Millions

When you think about diabetes, what’s the first thing that comes to mind? Chances are,

India’s pharma sector is at a turning point transitioning from a global generics powerhouse to

Healthcare major Manipal Hospitals has sought approval from the fair trade regulator CCI to acquire

Eleven listed hospital chains and two major unlisted players are expected to add around 14,500

Pharma major Eli Lilly today said that it’s weight loss drug Mounjaro has helped in

India’s largest drug maker Sun Pharmaceutical has no plans to further expand its manufacturing base

New Delhi: Healthcare costs in the US will increase following the imposition of sweeping 25

Seventy percent enrolment of participants for the Phase III clinical trial of the indigenous one-shot

Apollo Group entities have sought the Competition Commission of India’s (CCI) approval for a composite

If you’re living with type 2 diabetes (T2D), obesity, or both, you’re not alone. Millions

Indian manufacturers of medical devices have alleged that several private hospitals and retailers, in the

Piramal Healthcare will focus on organic expansion as its primary growth driver for the next

Mumbai: KKR, TPG, Kedaara Capital, and Multiples Alternate Asset Management are among homegrown and global

New Delhi: Drug regulator DCGI has asked drug controllers of all states and Union Territories

Mumbai: Torrent Pharmaceuticals is planning to catch the first wave of semaglutide launch once Danish

Alembic Pharmaceuticals on Monday said it has received final approval from the US health regulator

India’s cell and gene therapy pioneer ImmunoAct has turned profitable in its first full year

The All-India Organisation of Chemists and Druggists (AIOCD), representing over 12.40 lakh chemists across India,

Fatty liver disease was once considered a relatively rare and benign condition. It now has

Mumbai: Cipla aims to achieve $1 billion sales in the US by the next fiscal

Mumbai: Experts in intellectual property law and civil society groups in India have raised concerns

The Delhi government has directed all pharmaceutical and medical shops to install CCTV cameras on

The India-UK FTA is expected to give a strong tailwind to India’s pharmaceutical and medical

Zydus Lifesciences Ltd on Thursday said it has received tentative approval from the US health

Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy’s Labs

Biocon on Wednesday said its subsidiary Biocon Biologics has launched a product for the treatment

New Delhi: Civil society organisations have approached the health ministry, seeking to remove animal studies

India is rapidly transforming into a crucial focal point for the global weight management industry,

Abu Dhabi Investment Authority (ADIA) has signed a definitive agreement to invest $200 million (about

MUMBAI: Buyout groups Brookfield and EQT are in active discussions to buy Hyderabad-based Gland Pharma,

Mumbai: The Delhi High Court has issued an interim injunction against Ahmedabad-based drug maker Zydus

The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB)

Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI’s clearance to acquire a majority stake

Mumbai: Indians are increasingly popping over-the-counter pills, using sprays or rubbing in creams to soothe

The central drugs laboratories have found 55 samples manufactured by various firms in June to

Kenvue, a consumer health company and makers of Benadryl cough syrup, on Friday announced the

Glenmark Pharmaceuticals will turn net cash positive on its licensing deal with AbbVie Inc, according

CORONA Remedies on Thursday said it has acquired seven brands from the pharmaceutical division of

Glenmark Pharmaceuticals is pivoting to a sharper, innovation-driven company over the next 4-5 years with

New Delhi: Biocon Biologics on Wednesday said it has received approval from the US health

New-age weight-loss molecules have taken over the anti-obesity drug market in India, with tirzepatide and

Singapore investment fund Temasek is building on its investment strategy in India with a focus

New Delhi: Multi specialty hospital platform Marengo Asia Healthcare plans to soon foray into Maharashtra

New Delhi: Biosimilars are poised to drive the next wave of growth in the Indian

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot

Drug major Cipla is preparing to foray into the weight management segment in India, its

The WHO has acknowledged India’s efforts in integrating Artificial Intelligence (AI) with traditional medicine systems,

Indian pharma and healthcare sector will witness steady revenue growth in the first quarter of

Mumbai: Wockhardt will exit its loss-making generics business in the US as part of its

Ichnos Glenmark Innovation (IGI), an alliance between New York-based scientific research group Ichnos Sciences and

The Postgraduate Institute of Medical Education and Research (PGIMER) here on Thursday said that a

The Ontario Teachers’ Pension Plan Board (Ontario Teachers’) announced on July 9 its decision to

Manipal Health Enterprises, India’s 2nd largest hospital chain, has bought Sahyadri Hospitals from Canada’s Ontario

Welcure Drugs & Pharmaceuticals on Tuesday said it has completed seven export-sourcing orders of nearly

New Delhi: A significant dip in exports has prompted pharma lobby groups to raise a

Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation

Drug major Sun Pharmaceutical Industries aims to bolster compliance across its manufacturing operations and work

The CBI has conducted searches at the premises of Pharmacy Council of India (PCI) President

Union Minister of Health and Family Welfare JP Nadda and Delhi Chief Minister Rekha Gupta

An institute of the DRDO has signed an agreement with AIIMS, Rishikesh for conducting “clinical

There is no association between premature cardiovascular disease in a patient and a prior history

Pharma major Lupin Ltd on Friday said it has launched Ipratropium Bromide nasal spray, used

New Delhi: Growing quality concerns in the pharmaceutical industry has prompted government’s think tank Niti

Leading drugmakers on Thursday rallied in support of Covid vaccines, using various social media platforms,

Ahmedabad-based drug maker Torrent Pharmaceuticals Torrent Pharmaceuticals Ltd has signed a share purchase agreement to

The Delhi High Court on Tuesday directed India’s drug regulator to respond to a public

New Delhi: Covid-19 vaccines did not increase the risk of sudden death among young adults

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s

The recent death of Shefali Jariwala, best known for the 2002 chartbuster ‘Kaanta Laga’, due

Welcure Drugs & Pharmaceuticals on Tuesday said it has bagged two export orders worth Rs

Ahmedabad-based drug maker Torrent Pharmaceuticals will complete its acquisition of JB Chemicals & Pharmaceuticals in

Ahmedabad-based drugmaker Torrent Pharma has agreed to buy a controlling stake in JB Chemicals from

Torrent Pharmaceuticals, the flagship company of the Torrent Group, announced on Sunday that it will

Torrent Pharmaceuticals and JB Chemicals & Pharmaceuticals are working with advisers to firm up the

Aurobindo Pharma is recalling over 4,600 bottles of a pain relieving drug in the US

Torrent Pharma is in advanced discussions with private equity group KKR to buy JB Chemicals

Mumbai: A high-dose MIBG (metaiodobenzylguanidine) therapy for treating neuroblastoma, a type of cancer mostly found

Indian drugmaker Biocon has abandoned plans to market generic versions of Novo Nordisk’s hot-selling diabetes

Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with

Bharat Biotech and GSK have decided to progressively reduce the price of their malaria vaccine

Pharma major Lupin Ltd on Wednesday said it has received approval from the US health

Indian pharmaceutical and biotech sectors have started witnessing tangible benefits from the global shift away

With the launch of Wegovy by Novo Nordisk in India, the country’s obesity drugs sector

MUMBAI: Danish drug giant Novo Nordisk is aiming to hit $1 billion (Rs 8,600 crore)

Sickle cell anaemia tests have become much more affordable, with the government driving the prices

Amazon India on Sunday announced the launch of Amazon Diagnostics, an at-home service for customers

The US Food and Drug Administration (FDA) has approved lenacapavir, a new injectable drug that

Dermatology clinics are the new beauty salons. Consumers in urban India are no longer walking

New Delhi: Eli Lilly said on Saturday that its anti-obesity pill, Orforglipron, has shown significant

High-school freshman Austin Smith sank into depression from the merciless teasing and bullying he endured

Bengaluru | New Delhi: For 31-year-old techie Kumar, long hours at work carrying well into

The US Food and Drug Administration on Wednesday approved Gilead Sciences’ twice-yearly injection to prevent

Natco Pharma on Thursday said the US health regulator has issued a Form 483 with

New Delhi: Thousands of pharmaceutical companies in the micro, small and medium enterprise (MSME) sector

Welcure Drugs & Pharmaceuticals on Wednesday said it has executed a definitive mandate for third-party

Ahmedabad-based Torrent Pharma is revving up for acquisitions in India as part of its plans

Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace,

Union Minister of State for Health Anupriya Patel said on Monday 70 per cent of

With the bidding deadline for Sahyadri Hospitals approaching on June 22, interested bidders including Manipal

The Niti Aayog is likely to suggest a major revamp of the All-India Institute of

Mumbai: For nearly thirty years, Kirti Ganorkar quietly stood at Sun Pharma as a rock,

Drug major Sun Pharma on Saturday said the US health regulator has issued a Form

Sun Pharmaceutical Industries has appointed Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi,

The Delhi High Court has refused to restrain Sun Pharmaceutical Industries and its wholly-owned subsidiary

New Delhi: Leading diagnostic chains are looking to scale up their operations amid surging Covid-19

Bharat Biotech on Thursday said it has partnered with GSK plc for the development of

Mumbai: India’s market for single-speciality hospitals is set to more than double to $31 billion

UAE-based companies Shaiva Group and Taranis Capital have committed to invest Rs 2,125 crore in

New Delhi: The Indian Pharmaceutical Alliance (IPA), IPA, a lobby group which represents large domestic

Dismissing allegations that Indian pharmaceutical companies copy products of Swiss firms, Commerce and Industry Minister

New Delhi: India’s drug regulatory authority has joined hands with the Department of Animal Husbandry

Glenmark Pharmaceuticals on Monday said it will launch cancer treatment drug zanubrutinib in India following

KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART

One moment Anushka (name changed) was a college student. Then her world turned upside down.

Mumbai: Sales of Mounjaro, Eli Lilly’s blockbuster weight-loss and diabetes drug, have touched Rs 24

New Delhi: With a focus on developing AI-based solutions that support key national health programmes

Dr Reddy’s Laboratories on Thursday said it has joined hands with global biotech firm Alvotech

Mumbai: Dr Reddy’s Laboratories has entered into a collaboration with Reykjavik, Iceland-based biotech company Alvotech

New Delhi: Prices of active pharmaceutical ingredients (API) used for manufacturing drugs are seeing a

Drugmaker Wockhardt on Friday said its novel antibiotic Zaynich has an addressable market opportunity of

Pharmaceuticals company Murae Organisor on Tuesday said its board will meet on June 13 to

With Covid-19 cases surging significantly, the Union ministry of health has advised people to avoid